Is Glucerna Good for Kidney Disease Patients?

Glucerna is not formulated for people with kidney disease, and using it without medical guidance can create real problems for anyone managing chronic kidney disease (CKD). The product is designed to help people with diabetes control blood sugar, but its mineral content, particularly potassium, can be unsuitable or outright risky for someone whose kidneys are no longer filtering effectively. That does not mean all nutritional supplements are off the table for kidney patients, but the right product depends on your stage of disease, whether you are on dialysis, and which nutrients your body is struggling to handle.

What Glucerna Is Designed to Do

Glucerna is a line of shakes and bars made by Abbott Nutrition, marketed specifically to people with diabetes or prediabetes. Its selling points center on slow-release carbohydrates intended to minimize blood sugar spikes, along with added fiber, vitamins, and minerals. For someone who has diabetes but otherwise healthy kidneys, these features make sense. The formula was never designed with kidney function in mind, though, and the distinction matters more than most people realize.

Many people with kidney disease also have diabetes, since diabetes is one of the leading causes of CKD. So the overlap in patient populations is enormous, and it is natural for someone managing both conditions to reach for a product that seems to address at least one of them. The problem is that what helps with blood sugar management can simultaneously strain compromised kidneys if the drink contains minerals the kidneys can no longer clear efficiently.

The Potassium Problem

The most direct concern with Glucerna for kidney patients is its potassium content. When kidneys lose filtering capacity, potassium builds up in the blood. Elevated potassium, known as hyperkalemia, can cause dangerous heart rhythm disturbances and, in severe cases, cardiac arrest. People with moderate to advanced CKD are typically advised to limit dietary potassium, and their dietitians pay close attention to every source.

Research published in the Journal of Renal Nutrition has specifically flagged this issue, noting that commercially available nutritional supplements like Glucerna, while appropriate for residents with general nutrition needs, may be too high in potassium to benefit CKD patients.¹ That finding is particularly relevant in long-term care settings where staff may default to whatever supplement is stocked in the facility kitchen. Someone with healthy kidneys can handle the extra potassium without trouble, but the same serving can push a CKD patient into a dangerous range.

A standard Glucerna shake contains somewhere in the range of 350 to 470 milligrams of potassium per serving, depending on the specific product in the line. For a person on a potassium-restricted diet who might be capped at roughly 2,000 milligrams per day, one shake can eat up a significant portion of their allowance before they have eaten any actual food. And because potassium does not appear prominently on most food labels in the way sodium does, people often underestimate how much they are consuming from these drinks.

Phosphorus Is the Other Mineral to Watch

Potassium gets most of the attention, but phosphorus is another mineral that accumulates when kidneys struggle. Excess phosphorus pulls calcium out of bones and deposits it in blood vessels and soft tissues. Over time, this accelerates bone weakening and cardiovascular calcification, both of which are already elevated risks in CKD. Kidney patients in later stages are often placed on phosphorus binders, medications taken with meals to trap phosphorus before it gets absorbed.

General-purpose nutritional supplements, including diabetes-focused ones like Glucerna, tend to contain added phosphorus as part of their vitamin and mineral blend. This is perfectly fine for the general population, but it adds another layer of complication for someone with impaired kidney function. The same Journal of Renal Nutrition paper that raised concerns about potassium in these supplements was addressing the broader challenge of managing mineral intake in CKD patients who depend on commercial formulas for part of their nutrition.¹

Renal-Specific Formulas Exist for a Reason

The supplement industry does make products specifically designed for people with kidney disease. These renal formulas are engineered with lower potassium, lower phosphorus, and adjusted protein levels compared to standard or diabetes-focused shakes. Brands like Nepro and Suplena (also made by Abbott, the same company behind Glucerna) are tailored for different stages of kidney disease and dialysis status. Nepro, for example, is formulated for dialysis patients who need higher calories and protein in a concentrated volume, while Suplena targets pre-dialysis CKD patients who need to limit protein.

The existence of these specialized products is itself evidence that general-purpose supplements are not adequate for this population. A renal formula accounts for the unique metabolic restrictions that CKD imposes, something Glucerna simply was not built to do. If you are managing both diabetes and kidney disease, a renal formula with slow-digesting carbohydrates would be the more appropriate category, though the specific product should be chosen with your dietitian or nephrologist.

When Nutritional Supplements Genuinely Help Kidney Patients

There is strong evidence that the right kind of oral nutritional supplement can make a meaningful difference for people on dialysis. One of the biggest nutritional threats in advanced kidney disease is protein-energy wasting, a condition where the body breaks down its own muscle and fat stores because calorie and protein intake are chronically too low. This is common in people on hemodialysis, and it is strongly linked to higher mortality and worse outcomes overall.²

The research on this front is encouraging. Oral nutritional supplements given during dialysis sessions have been shown to reduce mortality risk in hemodialysis patients.² A review of the evidence found that specific oral formulations administered during hemodialysis represent an effective and safe first-step intervention for preventing and treating protein-energy wasting when calorie and protein intakes have dropped too low.³ The key word is “specific.” These are not random supplements pulled off a pharmacy shelf. They are formulations designed for the metabolic reality of someone whose kidneys are being replaced by a machine several times a week.

The practical takeaway is not that kidney patients should avoid supplements, but that the wrong supplement can do more harm than good, while the right one at the right stage of disease can be genuinely life-extending.

Protein Needs Shift Dramatically Across CKD Stages

One of the most confusing aspects of kidney disease nutrition is that protein recommendations flip depending on where you are in the disease. Before dialysis, most CKD patients are advised to limit protein to slow the rate of kidney decline. The kidneys process the waste products of protein metabolism, so eating more protein means asking damaged kidneys to work harder. Glucerna contains a moderate amount of protein per serving, which may or may not align with a pre-dialysis patient’s restrictions depending on how much protein they are eating from food.

Once a patient starts dialysis, the picture reverses. Dialysis itself strips protein from the blood, and the body’s protein requirements jump significantly. Hemodialysis patients often need substantially more protein than the average adult, sometimes in the range of 1.0 to 1.2 grams per kilogram of body weight per day. At that point, a supplement with too little protein would be inadequate, while one with the wrong mineral profile would still be problematic. This is why renal-specific formulas come in different versions for different stages: the nutritional targets are genuinely different.

Glucerna’s protein content sits in a middle ground that does not align well with either scenario. It is not low enough for strict pre-dialysis restriction, and it is not high enough or mineral-appropriate for dialysis patients who need aggressive nutritional support.

Gastroparesis Adds Another Wrinkle

People with CKD are significantly more likely to develop gastroparesis, a condition where the stomach empties too slowly. Research using large patient cohorts found that CKD patients had more than four times the odds of gastroparesis compared to people without CKD, and the risk climbed as kidney function declined. Patients with end-stage renal disease had the highest risk, at roughly eight times the odds seen in people with healthy kidneys.⁴ Even among outpatients, CKD was associated with more than double the risk of developing gastroparesis.⁴

This matters for supplement choice because gastroparesis causes nausea, bloating, early fullness, and sometimes vomiting. A thick, fiber-rich shake like Glucerna can sit heavily in a stomach that is not emptying properly, making symptoms worse. People with gastroparesis often tolerate liquid calories better than solid food, but they may need lower-fiber, lower-fat formulations that move through the gut more easily. A renal-specific formula with a thinner consistency or a lower fiber load may be better tolerated than a diabetes-focused product designed to slow gastric emptying on purpose.

Why This Confusion Keeps Happening

The overlap between diabetes and kidney disease is the root of the problem. Roughly a third of people with diabetes eventually develop some degree of CKD, and diabetes is the single most common cause of kidney failure requiring dialysis. When someone has been using Glucerna for years to manage blood sugar and then gets diagnosed with kidney disease, the impulse is to keep using what has been working. Doctors and nurses in non-nephrology settings may not think to flag the supplement, either, because its diabetes label seems appropriate for a diabetic patient.

Long-term care facilities and nursing homes face this challenge constantly. The research that specifically named Glucerna as potentially too high in potassium for CKD patients was conducted in the context of healthcare communities where residents depend on whatever nutritional supplements are available on-site.¹ Stocking renal-specific formulas alongside diabetes formulas adds cost and complexity, and not every facility has a renal dietitian on staff to catch the mismatch. The result is that patients sometimes drink supplements that were never designed for their condition, simply because the facility does not stock the right alternative.

What to Do If You Have Both Diabetes and Kidney Disease

If you currently drink Glucerna and have been diagnosed with any stage of CKD, bring it up with your nephrologist or renal dietitian at your next appointment. Do not assume the product is safe just because it was fine before your kidney diagnosis. Your doctor can check your blood levels of potassium and phosphorus and tell you whether your current supplement is contributing to values that are creeping out of range.

Ask specifically about renal-specific formulas. Some are designed for people who also have diabetes and include slow-digesting carbohydrates similar to those in Glucerna, but with potassium and phosphorus dialed down. Your insurance or Medicare plan may cover medical nutrition therapy visits with a registered dietitian, which is especially valuable early in a CKD diagnosis when the dietary changes feel overwhelming.

If you are on dialysis and struggling to eat enough, talk to your dialysis unit’s staff about intradialytic supplements. These are typically provided during the dialysis session itself, which is convenient and ensures you are getting nutrition at a time when your body needs it most. The evidence supports their use for preventing the kind of muscle and weight loss that worsens outcomes in dialysis patients.³

Reading the Label Is Not Enough

A common assumption is that if you read the nutrition facts panel carefully, you can figure out whether a supplement is safe for your kidneys. In practice, this is harder than it sounds. Potassium labeling has only recently become mandatory on US food labels, and older stock or products sold outside the US may not list it prominently. Phosphorus is even trickier, because inorganic phosphorus additives used as stabilizers and emulsifiers are absorbed much more efficiently than the organic phosphorus found naturally in foods, and the label does not distinguish between the two forms. A supplement and a serving of cheese might list the same milligrams of phosphorus, but your body absorbs far more from the supplement.

Protein content also cannot be evaluated in isolation. Whether a given amount of protein is appropriate for you depends on your weight, your stage of kidney disease, your dialysis schedule if applicable, and what you are eating the rest of the day. A dietitian who specializes in renal nutrition can pull all of these variables together in a way that a label cannot. The label gives you data; the dietitian gives you context. For kidney patients, the context is where the real decisions happen.